Impact of a non-synonymous Q281R polymorphism on structure of human Lipoprotein-Associated Phospholipase A2 (Lp-PLA2)

被引:10
作者
Gurung, Arun B. [1 ]
Bhattacharjee, Atanu [1 ,2 ]
机构
[1] North Eastern Hill Univ, Dept Biotechnol & Bioinformat, Computat Biol Lab, Shillong 793022, Meghalaya, India
[2] North Eastern Hill Univ, Bioinformat Ctr, Shillong, Meghalaya, India
关键词
atherosclerosis; complex human diseases; lipoprotein-associated phospholipase A(2); non-synonymous single nucleotide polymorphism; pharmacogenomics; Q281R mutation; ACTIVATING-FACTOR-ACETYLHYDROLASE; SINGLE NUCLEOTIDE POLYMORPHISMS; PAF-ACETYLHYDROLASE; CARDIOVASCULAR-DISEASE; GENETIC-VARIATION; PROTEIN; DEFICIENCY; SEQUENCE; MUTATION; BINDING;
D O I
10.1002/jcb.26909
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Non-synonymous single nucleotide polymorphisms (nsSNPs) are genetic variations at single base resulting in an amino acid change which have been associated with various complex human diseases. The human Lipoprotein-associated phospholipase A(2) (Lp-PLA(2)) gene harbours a rare Q281R polymorphism which was previously reported to cause loss of enzymatic function. Lp-PLA(2) is an important enzyme which catalyzes the hydrolysis of polar phospholipids releasing pro-atherogenic and pro-inflammatory mediators involved in the pathogenesis of atherosclerosis. Our current study is aimed at elucidating the structural and functional consequences of Q281R polymorphism on Lp-PLA(2). The Q281R mutation is classified as deleterious and causes protein instability as deduced from evolutionary, folding free energy changes and Support vector machine (SVM)-based methods. A Q281R mutant structure was deciphered using homology modelling approach and was validated using phi and psi dihedral angles distribution, ERRAT, Verify_3D scores, Protein Structure Analysis (ProSA) energ,y and Z-score. A decreased hydrophobic interactions and weaker substrate binding affinity was observed in the mutant compared to the wild- type (WT) using molecular docking. Further, the mutant displayed enhanced structural flexibility particularly in the low density lipoprotein (LDL) binding domain, decreased solvent accessibility of catalytic residues-Phe274 and Ser273 and increased C? distance between Phe274 and Leu153 and large conformational entropy change as inferred from all-atom molecular dynamics (MD) simulation and essential dynamics (ED) studies. Our results corroborate well with previous experimental studies and thus these aberrations in the Q281R mutant structure may help explain the molecular basis of loss of enzyme activity.
引用
收藏
页码:7009 / 7021
页数:13
相关论文
共 50 条
  • [31] Distribution of Paraoxonase-1 (PON-1) and Lipoprotein Phospholipase A2 (Lp-PLA2) across Lipoprotein Subclasses in Subjects with Type 2 Diabetes
    Passaro, Angelina
    Vigna, Giovanni Battista
    Romani, Arianna
    Sanz, Juana M.
    Cavicchio, Carlotta
    Bonaccorsi, Gloria
    Valacchi, Giuseppe
    Cervellati, Carlo
    [J]. OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2018, 2018
  • [32] Association between Lipoprotein-Associated Phospholipase A2 Gene Polymorphism and Coronary Artery Disease in the Chinese Han Population
    Li, Liyun
    Qi, Liping
    Lv, Naqiang
    Gao, Qian
    Cheng, Yanmei
    Wei, Yingjie
    Ye, Jue
    Yan, Xiaowei
    Dang, Aimin
    [J]. ANNALS OF HUMAN GENETICS, 2011, 75 : 605 - 611
  • [33] Differential Expression of Lipoprotein-Associated Phospholipase A2 in Monocyte Subsets: Impact of Uremia and Atherosclerosis
    Ulrich, Christof
    Trojanowicz, Bogusz
    Fiedler, Roman
    Kohler, Felix
    Wolf, Anna-Franziska
    Seibert, Eric
    Girndt, Matthias
    [J]. NEPHRON, 2017, 135 (03) : 231 - 241
  • [34] Structure-Guided Discovery of Novel, Potent, and Orally Bioavailable Inhibitors of Lipoprotein-Associated Phospholipase A2
    Liu, Qiufeng
    Huang, Fubao
    Yuan, Xiaojing
    Wang, Kai
    Zou, Yi
    Shen, Jianhua
    Xu, Yechun
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2017, 60 (24) : 10231 - 10244
  • [35] 279val→phe Polymorphism of lipoprotein-associated phospholipase A2 resulted in changes of folding kinetics and recognition to substrate
    Masbuchin, Ainun Nizar
    Rohman, Mohammad Saifur
    Putri, Jayarani Fatimah
    Cahyaningtyas, Miryanti
    Widodo
    [J]. COMPUTATIONAL BIOLOGY AND CHEMISTRY, 2015, 59 : 199 - 207
  • [36] Effects of the direct lipoprotein-associated phospholipase A2 inhibitor darapladib on human coronary atherosclerotic plaque
    Serruys, Patrick W.
    Garcia-Garcia, Hector M.
    Buszman, Pawel
    Erne, Paul
    Verheye, Stefan
    Aschermann, Michael
    Duckers, Henrikus
    Bleie, Oyvind
    Dudek, Dariusz
    Botker, Hans Erik
    von Birgelen, Clemens
    D'Amico, Don
    Hutchinson, Tammy
    Zambanini, Andrew
    Mastik, Frits
    van Es, Gerrit-Anne
    van der Steen, Antonius F. W.
    Vince, D. Geoffrey
    Ganz, Peter
    Hamm, Christian W.
    Wijns, William
    Zalewski, Andrew
    [J]. CIRCULATION, 2008, 118 (11) : 1172 - 1182
  • [37] DNA methylome profiling reveals epigenetic regulation of lipoprotein-associated phospholipase A2 in human vulnerable atherosclerotic plaque
    Li, Jingjin
    Zhang, Xiaoping
    Yang, Mengxi
    Yang, Hang
    Xu, Ning
    Fan, Xueqiang
    Liu, Gang
    Jiang, Xintong
    Fan, Jiasai
    Zhang, Lifang
    Zhang, Hu
    Zhou, Ying
    Li, Rui
    Gao, Si
    Jin, Jiangli
    Jin, Zening
    Zheng, Jingang
    Tu, Qiang
    Ren, Jingyi
    [J]. CLINICAL EPIGENETICS, 2021, 13 (01)
  • [38] Effect of Darapladib on Plasma Lipoprotein-Associated Phospholipase A2 Activity in Japanese Dyslipidemic Patients, With Exploratory Analysis of a PLA2G7 Gene Polymorphism of Val279Phe
    Daida, Hiroyuki
    Iwase, Takayuki
    Yagi, Shigeru
    Ando, Hidekazu
    Nakajima, Hiromu
    [J]. CIRCULATION JOURNAL, 2013, 77 (06) : 1518 - 1525
  • [39] Effects of the Ala379Val polymorphism of lipoprotein-associated phospholipase A2 on thrombosis and inflammation in hypertensive patients
    Kardara, Despina
    Tousoulis, Dimitris
    Antoniades, Charalambos
    Koumallos, Nikolaos
    Xaplanteris, Panagiotis
    Kyvelou, Stella-Maria
    Papageorgiou, Nikolaos
    Vasiliadou, Carmen
    Vlachopoulos, Charalambos
    Stefanadis, Christodoulos
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2011, 152 (02) : 247 - 249
  • [40] Strategies for vascular disease prevention: The role of lipids and related markers including apolipoproteins, low-density lipoproteins (LDL)-particle size, high sensitivity C-reactive protein (hs-CRP), lipoprotein-associated phospholipase A2 (Lp-PLA2) and lipoprotein(a) (Lp(a))
    Dallmeier, Dhayana
    Koenig, Wolfgang
    [J]. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2014, 28 (03) : 281 - 294